Dr. Rinn is an experienced medical oncologist, specializing in breast cancer. She recognizes that breast cancer is often a challenging diagnosis with a ripple effect disruptive to people’s lives. Dr. Rinn explains treatment options thoroughly to partner with patients in their decision making. She enjoys getting to know people and helping them through their diagnosis and treatment. Additional areas of interest include breast cancer prevention, genetics and clinical research. Dr. Rinn is always striving to make cancer treatment better for her patients.
In her free time, Dr. Rinn enjoys spending time outdoors, hiking with her family, paddleboarding and throwing ball for her dog.
Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients With Early Stage TNBC-Phase I (B-STRONGER-I).
View DetailsA Phase 1b/2, Open-Label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE).
View DetailsA Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer.
View DetailsA Phase 3 Study to Evaluate the Efficacy and Safety of Enobosarm in Combination with Abemaciclib (Enobosarm Combination Group) compared to Estrogen Blocking Agent (Control Treatment Group) for the Second Line Treatment of ER+HER2- Metastatic Breast Cancer in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent plus Palbociclib.
View DetailsMulticenter Open Label Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients with Brain Metastasis due to HR+/Her2- Breast Cancer.
View Details
